EQT Life Sciences, formerly LSP, is one of Europe’s largest and most experienced Life Sciences investors with a 30-year history. The firm targets innovative companies focusing on the development of therapeutics, medical devices, diagnostics and healthtech globally. EQT Life Sciences has raised around 3.5 billion euros across 12 private funds and 3 investment strategies. With a dedicated team of highly experienced investment professionals, coming from backgrounds in medicine and science, EQT Life Sciences aims to back the smartest inventors who have ideas that could truly make a difference for patients.
Access investment thesis, focus areas, bio, and contact details for Albert Gustafsson and 22,000+ other VC professionals.
Amsterdam, NL